• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heron Therapeutics, Inc. - Common Stock (NQ:HRTX)

0.4333 +0.0147 (+3.51%)
Official Closing Price Updated: 4:15 PM EDT, Jun 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,628,512
Open 0.4150
Bid (Size) 0.4203 (5,000)
Ask (Size) 0.4316 (100)
Prev. Close 0.4186
Today's Range 0.4135 - 0.4584
52wk Range 0.3820 - 2.300
Shares Outstanding 140,759,276
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Keep an eye on the top gainers and losers in Tuesday's session. ↗
June 02, 2026
Via Chartmill
These stocks are moving in today's session ↗
June 02, 2026
Via Chartmill

Performance

YTD
-65.6%
-65.6%
1 Month
-50.9%
-50.9%
3 Month
-45.6%
-45.6%
6 Month
-66.1%
-66.1%
1 Year
-79.8%
-79.8%

More News

Read More
Tuesday's session: gap up and gap down stocks ↗
June 02, 2026
Via Chartmill
News headline image
U.S. District Court Issues Decision Regarding CINVANTI® Patents
June 02, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
Heron Therapeutics Q1 Results Miss, but Acute Care Growth and Reaffirmed Outlook Support HRTX ↗
May 11, 2026
Via Chartmill
Heron Therapeutics Inc (NASDAQ:HRTX) Reports Q4 2025 Revenue Beat and Positive 2026 Outlook ↗
February 26, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
Via Benzinga
Which stocks are moving after the closing bell on Monday? ↗
June 01, 2026
Via Chartmill
News headline image
Heron (HRTX) Q1 2026 Earnings Call Transcript ↗
May 11, 2026
Via The Motley Fool
Topics Earnings Supply Chain
Which stocks are moving on Monday? ↗
May 11, 2026
Via Chartmill
News headline image
Heron Therapeutics Q1 Earnings Call Highlights ↗
May 11, 2026
Via MarketBeat
Topics Earnings
The market is filled with gapping stocks in Monday's session. ↗
May 11, 2026
Via Chartmill
News headline image
Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance
May 11, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026
April 27, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron (HRTX) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Via The Motley Fool
Topics Earnings
News headline image
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
February 17, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth
January 09, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)
December 04, 2025
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics Inc (NASDAQ:HRTX) Reports Mixed Q3 2025 Results, Misses Revenue and Earnings Estimates ↗
November 04, 2025
Via Chartmill
News headline image
Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress
November 04, 2025
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
October 29, 2025
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
October 21, 2025
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
August 08, 2025
Via Benzinga
News headline image
These stocks are moving in today's session ↗
August 08, 2025
Via Chartmill

Frequently Asked Questions

Is Heron Therapeutics, Inc. - Common Stock publicly traded?
Yes, Heron Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Heron Therapeutics, Inc. - Common Stock trade on?
Heron Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Heron Therapeutics, Inc. - Common Stock?
The ticker symbol for Heron Therapeutics, Inc. - Common Stock is HRTX on the Nasdaq Stock Market
What is the current price of Heron Therapeutics, Inc. - Common Stock?
The current price of Heron Therapeutics, Inc. - Common Stock is 0.4333
When was Heron Therapeutics, Inc. - Common Stock last traded?
The last trade of Heron Therapeutics, Inc. - Common Stock was at 06/24/26 04:15 PM ET
What is the market capitalization of Heron Therapeutics, Inc. - Common Stock?
The market capitalization of Heron Therapeutics, Inc. - Common Stock is 60.99M
How many shares of Heron Therapeutics, Inc. - Common Stock are outstanding?
Heron Therapeutics, Inc. - Common Stock has 61M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap